NO137861C - Fremgangsmaate til fremstilling av meget loeselig gammaglobulin - Google Patents

Fremgangsmaate til fremstilling av meget loeselig gammaglobulin

Info

Publication number
NO137861C
NO137861C NO4490/73A NO449073A NO137861C NO 137861 C NO137861 C NO 137861C NO 4490/73 A NO4490/73 A NO 4490/73A NO 449073 A NO449073 A NO 449073A NO 137861 C NO137861 C NO 137861C
Authority
NO
Norway
Prior art keywords
gammaglobulin
soluble
preparing
procedure
soluble gammaglobulin
Prior art date
Application number
NO4490/73A
Other languages
English (en)
Norwegian (no)
Other versions
NO137861B (no
Inventor
John H Payne
Guido A Ordonez
Luis A Garcia
Original Assignee
Baxter Travenol Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Baxter Travenol Lab filed Critical Baxter Travenol Lab
Publication of NO137861B publication Critical patent/NO137861B/no
Publication of NO137861C publication Critical patent/NO137861C/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/06Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies from serum

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
NO4490/73A 1972-11-27 1973-11-26 Fremgangsmaate til fremstilling av meget loeselig gammaglobulin NO137861C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US30984172A 1972-11-27 1972-11-27

Publications (2)

Publication Number Publication Date
NO137861B NO137861B (no) 1978-03-30
NO137861C true NO137861C (no) 1978-05-10

Family

ID=23199896

Family Applications (1)

Application Number Title Priority Date Filing Date
NO4490/73A NO137861C (no) 1972-11-27 1973-11-26 Fremgangsmaate til fremstilling av meget loeselig gammaglobulin

Country Status (16)

Country Link
JP (1) JPS5843371B2 (ja)
AT (1) AT325208B (ja)
AU (1) AU6265873A (ja)
BE (1) BE807527A (ja)
CA (1) CA1016069A (ja)
DE (1) DE2357800A1 (ja)
DK (1) DK135270B (ja)
ES (1) ES420846A1 (ja)
FR (1) FR2207698B1 (ja)
GB (1) GB1435816A (ja)
IL (1) IL43643A (ja)
IT (1) IT1196391B (ja)
NL (1) NL7315859A (ja)
NO (1) NO137861C (ja)
SE (1) SE390795B (ja)
ZA (1) ZA738779B (ja)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2364792A1 (de) * 1973-01-15 1974-07-18 South African Inventions Verfahren zum reinigen von gammaglobulin
DE2500076C3 (de) * 1975-01-02 1982-11-18 SCHURA Blutderivate GmbH & Co KG, 4150 Krefeld Verfahren zur Gewinnung von intravenös-verträglichen Gammaglobulinen
US4057628A (en) * 1976-04-19 1977-11-08 William L. Wilson Removal of hepatitis associated antigen from plasma
JPS6016406B2 (ja) * 1976-08-06 1985-04-25 マイヤ−、ル−イス、コ−バル 静脈内に投与可能なガンマ・グロブリンの製造法ならびにそれにより調製したガンマ・グロブリン
JPS5347515A (en) * 1976-10-13 1978-04-28 Green Cross Corp:The Gamma-globulin pharmaceutical preparation for intravenous injection
US4124576A (en) * 1976-12-03 1978-11-07 Coval M L Method of producing intravenously injectable gamma globulin
US4272521A (en) * 1979-07-16 1981-06-09 Cutter Laboratories, Inc. Purified immune serum globulin
JPS5732228A (en) * 1980-08-05 1982-02-20 Green Cross Corp:The Preparation of immunoglobulin usable for intravenous injection
ATE17654T1 (de) * 1981-10-29 1986-02-15 Green Cross Corp Verfahren zur herstellung von intravenoesem injizierbarem immunoglobulin.
JPS58180433A (ja) * 1982-04-16 1983-10-21 Fujirebio Inc 免疫グロブリンから抗補体作用物質の除去法

Also Published As

Publication number Publication date
AU6265873A (en) 1975-05-22
FR2207698A1 (ja) 1974-06-21
ES420846A1 (es) 1976-06-16
AT325208B (de) 1975-10-10
DK135270C (ja) 1977-09-19
NL7315859A (ja) 1974-05-29
GB1435816A (en) 1976-05-19
FR2207698B1 (ja) 1976-09-03
IL43643A (en) 1976-10-31
BE807527A (fr) 1974-03-15
CA1016069A (en) 1977-08-23
JPS4981519A (ja) 1974-08-06
DK135270B (da) 1977-03-28
DE2357800A1 (de) 1974-06-06
ZA738779B (en) 1974-10-30
IL43643A0 (en) 1974-03-14
IT1196391B (it) 1988-11-16
SE390795B (sv) 1977-01-24
JPS5843371B2 (ja) 1983-09-27
NO137861B (no) 1978-03-30

Similar Documents

Publication Publication Date Title
SE395366B (sv) Forfarande for framstellning av porosa tabletter
SE404019B (sv) Forfarande for framstellnig av n-fosfonometylglycin
SE400771B (sv) Forfarande for framstellning av 3alfa-hydroxi- och 3alfa-hydroxi-19-norpregnaner
SE415261B (sv) Forfarande for framstellning av berarbundna polypeptider
SE413246B (sv) Forfarande for framstellning av kolesteroloxidas
SE417968B (sv) Forfarande for framstellning av penamderivat
SE419339B (sv) Forfarande for framstellning av substituerade sulfonylacetamidocefalosporiner
SE397530B (sv) Forfarande for framstellning av 1-pyrazolylalkyl-4-arylpiperazinderivat
NO140828C (no) Fremgangsmaate for fremstilling av pullulan
NO139124C (no) Fremgangsmaate for fremstilling av estere
NO137861C (no) Fremgangsmaate til fremstilling av meget loeselig gammaglobulin
SE423092B (sv) Forfarande for framstellning av vissa 13-tiaprostaglandiner
SE7611202L (sv) Forfarande for framstellning av pyrazolodiazepinforeningar
FI55626C (fi) Anordning foer framstaellning av en behaollare
NO139130C (no) Fremgangsmaate til fremstilling av 2-alkylamino-dihydropyridiner
SE387344B (sv) Forfarande for framstellning av pyrazin-4-oxidderivat
SE393376B (sv) Forfarande for framstellning av pyrimidinonderivat
SE385581B (sv) Forfarande for framstellning av foretrade n-metylolkarbamidforeningar
DK131864C (da) Fremgangsmade til fremstilling af pregnan-21-syrederivater
SE402454B (sv) Forfarande for framstellning av 2-alkoxi-5-alkylsulfonyl-toluen
NO140185C (no) Fremgangsmaate til fremstilling av indolderivater
NO139353C (no) Fremgangsmaate til fremstilling av lipase
SE410315B (sv) Forfarande for framstellning av pyrazolderivat
SE419441B (sv) Forfarande for framstellning av butyrofenonderivat
SE415974B (sv) Forfarande for framstellning av 2-bensoyl-3-amino-pyridinderivat